US Broker Ratings

Verastem, Inc. (VSTM) Stock Analysis: Exploring the 106% Potential Upside with Robust Buy Ratings

Verastem, Inc. (NASDAQ: VSTM), a biopharmaceutical company focused on developing cancer therapies, has recently captured the attention of investors with its significant potential upside. With a market capitalization of $583.73..

Upstream Bio, Inc. (UPB) Stock Analysis: Navigating a 57.40% Potential Upside in the Biotech Sector

Upstream Bio, Inc. (NASDAQ: UPB) is emerging as a promising player in the biotechnology sector, with a focus on developing innovative treatments for severe respiratory disorders. The clinical-stage company’s flagship..

Butterfly Network, Inc. (BFLY) Stock Analysis: A Promising 13.53% Upside in the Medical Devices Sector

Investors eyeing opportunities in the healthcare sector may find Butterfly Network, Inc. (NASDAQ: BFLY) an intriguing proposition. With a market capitalization of $871.48 million, this Massachusetts-based medical devices company is..

InnovAge Holding Corp. (INNV) Stock Analysis: Navigating a 15% Revenue Growth with Caution

InnovAge Holding Corp. (NASDAQ: INNV) stands at the intersection of healthcare innovation and community-based elder care. As a prominent player in the medical care facilities industry, InnovAge operates under the..

Sonida Senior Living, Inc. (SNDA) Stock Analysis: A Deep Dive into the Healthcare Sector with a 25.9% Revenue Growth

Sonida Senior Living, Inc. (NASDAQ: SNDA), a prominent player in the U.S. senior housing market, is capturing investor attention with its recent performance. With a robust 25.9% revenue growth, the..

ArriVent BioPharma, Inc. (AVBP) Stock Analysis: Exploring an 89.81% Potential Upside in the Biotech Sector

ArriVent BioPharma, Inc. (NASDAQ: AVBP), a clinical-stage biopharmaceutical company, is positioned at the intersection of innovation and opportunity within the biotechnology sector. With a market capitalization of $873.93 million and..

CareDx, Inc. (CDNA) Stock Analysis: A 19.85% Upside Potential in the Healthcare Sector

CareDx, Inc. (NASDAQ: CDNA), a key player in the healthcare sector, is drawing attention from investors with its promising potential for growth in the diagnostics and research industry. Headquartered in..

Amylyx Pharmaceuticals (AMLX): Investor Outlook with a Promising 70% Upside Potential

Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) presents an intriguing opportunity for investors with a keen interest in the biotechnology sector. With a market capitalization of $1.31 billion, the clinical-stage pharmaceutical company..

Capricor Therapeutics, Inc. (CAPR) Stock Analysis: Exploring a 93.97% Potential Upside Amid Strong Buy Ratings

Capricor Therapeutics, Inc. (NASDAQ: CAPR) is capturing the attention of investors with its dynamic presence in the biotechnology sector, specifically focusing on transformative cell and exosome-based therapeutics. With a market..

Akebia Therapeutics, Inc. (AKBA) Rating Update: Analysts Eye 223% Upside Potential

Akebia Therapeutics, Inc. (NASDAQ: AKBA) has positioned itself as a notable player in the healthcare sector, specifically in the specialty and generic drug manufacturing industry. Headquartered in Cambridge, Massachusetts, this..

Castle Biosciences, Inc. (CSTL) Stock Analysis: Navigating the Diagnostics Frontier with Analyst Confidence

Castle Biosciences, Inc. (NASDAQ: CSTL), a company rooted in the burgeoning healthcare sector, specifically in diagnostics and research, continues to make waves with its cutting-edge molecular diagnostics solutions. Headquartered in..

Geron Corporation (GERN) Stock Analysis: High Analyst Ratings Signal a 168% Upside Potential

Geron Corporation (NASDAQ: GERN), a biopharmaceutical entity with a focus on oncology, is capturing investor attention with its ambitious growth trajectory and significant upside potential. Headquartered in Foster City, California,..

Kura Oncology, Inc. (KURA) Investor Outlook: Unveiling a Potential 235% Upside with Innovative Cancer Therapies

Kura Oncology, Inc. (NASDAQ: KURA) is making waves in the biotechnology sector with its cutting-edge cancer therapies, capturing the attention of both analysts and investors alike. With a current market..

Vir Biotechnology, Inc. (VIR) Stock Analysis: Exploring a 190% Upside Potential Amidst Challenging Financials

Vir Biotechnology, Inc. (NASDAQ: VIR) is generating buzz in the healthcare sector, particularly in biotechnology, with an enticing potential upside of 190.43%. As a clinical-stage biopharmaceutical company, Vir focuses on..

Cronos Group Inc. (CRON) Stock Analysis: Navigating the Cannabis Sector with a Unique Market Position

Cronos Group Inc. (NASDAQ: CRON), a prominent player in the cannabinoid industry, is capturing investor attention with its innovative approaches and strategic market positioning. Based in Stayner, Canada, Cronos is..

Xeris Biopharma Holdings, Inc. (XERS)

⚠️ No article content returned.

..

Valneva SE (VALN) Stock Analysis: Exploring the 58% Upside Potential in the Biotech Sector

Valneva SE (VALN), a French biotechnology company, is capturing the attention of investors with its ambitious vaccine portfolio focused on infectious diseases with unmet needs. As the healthcare sector continues..

Talkspace, Inc. (TALK) Investor Outlook: A Healthcare Disruptor with 34.92% Potential Upside

Talkspace, Inc. (NASDAQ: TALK) is making waves in the healthcare sector with its innovative approach to mental health services. As a virtual behavioral healthcare company, Talkspace connects patients with licensed..

AbCellera Biologics Inc. (ABCL) Stock Report: Exploring a Potential 178% Upside

AbCellera Biologics Inc. (NASDAQ: ABCL), a key player in the biotechnology sector, has caught the attention of investors with its promising potential upside of 178.56%. As a Canadian company specializing..

Keros Therapeutics, Inc. (KROS) Investor Outlook: A 16% Upside Potential with Robust Revenue Growth

Keros Therapeutics, Inc. (NASDAQ: KROS), a burgeoning player in the biotechnology sector, has been capturing investor attention with its impressive revenue growth and promising pipeline of therapeutics. With a market..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds